Category: Membership
-
We did it. Now let’s keep pushing.
In September, the FDA held a public hearing on Psychedelic Drug Therapy, with 80 speakers highlighting the need for representation. Oregon’s Health Authority reversed planned fee increases for Psilocybin Services after widespread community advocacy. The importance of collective action was emphasized, encouraging facilitators to join forces and participate actively to influence future changes.
-
Why the Psychedelic-Assisted Care Field Needs an Association — And Why We Hope It’s Us
If you’re reading this, you already know something the rest of the world is just catching up on: this work is powerful, it’s hard, and it’s lonely in ways that surprise even the most prepared practitioner. You went through training, built a practice or joined a service center, and somewhere along the way realized no…
-
Advocacy Mid-Year Check In
In the first half of 2026, Kathryn Tucker significantly advanced psychedelic medicine advocacy and education, reaching diverse audiences through webinars, podcasts, and in-person events. Her efforts contributed to the historic signing of a Presidential Executive Order on psychedelic policy reform, reflecting her influential role in shaping legal and public perspectives on the subject.